⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

March 11, 2016VaccineOpen Access

Status of vaccine research and development of vaccines for dengue

Kirsten Vannice Anna P. Durbin Joachim Hombach

View Full Paper

Ask AI

Bookmark

Share

Abstract

This review on the dengue vaccine pipeline was a solicited article and drafted based on the pre-defined template for PD-VAC.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Vannice et al. (2016) studied this question.

synapsesocial.com/papers/6a16fa4566334ab13b058dfe https://doi.org/10.1016/j.vaccine.2015.12.073

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Differences between Canadian parents’ attitudes toward routine, influenza, and COVID-19 vaccines for their children, and changes in vaccine hesitancy since the pandemic: A national cross-sectional comparative studyVaccine · 2026
2A qualitative examination of factors impacting Black and Latino sexual minority men's vaccination decision-making and experiences: application of the stages of vaccine readiness and action theoretical frameworkVaccine · 2026
3Exploring perceptions of 4CMenB vaccination for gonorrhoea prevention among gay, bisexual and other men who have sex with men and healthcare professionals in England: a qualitative focus group studyVaccine · 2026
4Boosting hybrid immunity with intranasal live-attenuated or intramuscular mRNA vaccination prevents SARS-CoV-2 XBB.1.5 transmissionVaccine · 2026
5Exposure to natural disasters and vaccination indicators: a systematic review and directions for future researchVaccine · 2026

Faster waning of immunity to influenza vaccine strains reintroduced into subsequent seasons: A human cohort studyVaccine · 2026
Monitoring of adverse events following 2024–2025 BNT162b2 KP.2 COVID-19 vaccination in the United StatesVaccine · 2026
Hemagglutinin- and neuraminidase-targeting antibody responses after receipt of egg-based inactivated or recombinant influenza vaccines among adults aged 18–64 yearsVaccine · 2026
mRNA encoding norovirus VP1 produces antigenically functional virus-like particles in vitroVaccine · 2026
Ischemic stroke after bivalent mRNA COVID-19 vaccination and influenza vaccination during the 2022–2023 season: a multi-site self-controlled case series studyVaccine · 2026

More from Vaccine

More from Johns Hopkins University

More from World Health Organization